Betamethasone valerate patch - IBSA

Drug Profile

Betamethasone valerate patch - IBSA

Alternative Names: Betasil Plaster; Beteflam Patch; Betesil Patch

Latest Information Update: 09 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator IBSA
  • Developer Cipher Pharmaceuticals; IBSA
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics; Fluorinated steroids; Glucocorticoids; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis; Skin disorders
  • Phase III Musculoskeletal disorders

Most Recent Events

  • 05 Apr 2016 Launched for Plaque psoriasis in Canada (Topical)
  • 05 Apr 2016 Pooled efficacy and adverse events data from two phase III trials in Plaque psoriasis released by IBSA
  • 01 Mar 2016 IBSA completes a phase III clinical trial in Musculoskeletal disorders (In adults, In the elderly) in Italy (Topical) (EudraCT2014-004119-35 )
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top